145 related articles for article (PubMed ID: 38061853)
1. Systematic approach to diagnosing suspected Creutzfeldt-Jakob disease.
Rode MM; Itoh C; Martinez-Sosa S; Ebner BA; Chang BK; Flanagan EP; Pinto MV
BMJ Case Rep; 2023 Dec; 16(12):. PubMed ID: 38061853
[TBL] [Abstract][Full Text] [Related]
2. Cerebrospinal fluid biomarker supported diagnosis of Creutzfeldt-Jakob disease and rapid dementias: a longitudinal multicentre study over 10 years.
Stoeck K; Sanchez-Juan P; Gawinecka J; Green A; Ladogana A; Pocchiari M; Sanchez-Valle R; Mitrova E; Sklaviadis T; Kulczycki J; Slivarichova D; Saiz A; Calero M; Knight R; Aguzzi A; Laplanche JL; Peoc'h K; Schelzke G; Karch A; van Duijn CM; Zerr I
Brain; 2012 Oct; 135(Pt 10):3051-61. PubMed ID: 23012332
[TBL] [Abstract][Full Text] [Related]
3. Low mood, visual hallucinations, and falls - heralding the onset of rapidly progressive probable sporadic Creutzfeldt-Jakob disease in a 73-year old: a case report.
Klotz DM; Penfold RS
J Med Case Rep; 2018 May; 12(1):128. PubMed ID: 29734943
[TBL] [Abstract][Full Text] [Related]
4. Alzheimer's disease cerebrospinal fluid biomarkers differentiate patients with Creutzfeldt-Jakob disease and autoimmune encephalitis.
Chang BK; Day GS; Graff-Radford J; McKeon A; Flanagan EP; Algeciras-Schimnich A; Mielke MM; Nguyen A; Jones DT; Toledano M; Kremers WK; Knopman DS; Petersen RC; Li W
Eur J Neurol; 2022 Oct; 29(10):2905-2912. PubMed ID: 35735602
[TBL] [Abstract][Full Text] [Related]
5. Determination of neuronal antibodies in suspected and definite Creutzfeldt-Jakob disease.
Grau-Rivera O; Sánchez-Valle R; Saiz A; Molinuevo JL; Bernabé R; Munteis E; Pujadas F; Salvador A; Saura J; Ugarte A; Titulaer M; Dalmau J; Graus F
JAMA Neurol; 2014 Jan; 71(1):74-8. PubMed ID: 24248099
[TBL] [Abstract][Full Text] [Related]
6. Atypical presentation of probable Creutzfeldt-Jakob disease associated with anti-Zic4 antibody: Literature review of neuronal antibodies in Creutzfeldt-Jakob disease.
Salazar R
Clin Neurol Neurosurg; 2018 May; 168():72-76. PubMed ID: 29525731
[TBL] [Abstract][Full Text] [Related]
7. Cerebrospinal Fluid Biomarkers in the Diagnosis of Creutzfeldt-Jakob Disease in Slovak Patients: over 10-Year Period Review.
Koscova S; Zakova Slivarichova D; Tomeckova I; Melicherova K; Stelzer M; Janakova A; Kosorinova D; Belay G; Mitrova E
Mol Neurobiol; 2017 Oct; 54(8):5919-5927. PubMed ID: 27665282
[TBL] [Abstract][Full Text] [Related]
8. [Psychiatric manifestations of a new variant of Creutzfeldt-Jakob disease. Apropos of a case].
Dervaux A; Vicart S; Lopes F; Le Borgne MH
Encephale; 2001; 27(2):194-7. PubMed ID: 11407273
[TBL] [Abstract][Full Text] [Related]
9. Clinical Correlates of Cerebrospinal Fluid 14-3-3 Protein in Non-Prion Rapid Progressive Dementia.
Kong Y; Chen Z; Shi Q; Zuo Y; Zhang J
J Alzheimers Dis; 2023; 91(1):263-272. PubMed ID: 36404548
[TBL] [Abstract][Full Text] [Related]
10. Young-onset sporadic Creutzfeldt-Jakob disease with atypical phenotypic features: a case report.
Lahiri D; Pattnaik S; Bhat A; Dubey S; Biswas A; Roy BK
J Med Case Rep; 2019 May; 13(1):163. PubMed ID: 31138302
[TBL] [Abstract][Full Text] [Related]
11. Role of the biomarkers for the diagnosis of Creutzfeldt-Jakob disease.
Dulamea A; Solomon E
J Med Life; 2016; 9(2):211-5. PubMed ID: 27453757
[TBL] [Abstract][Full Text] [Related]
12. Symptomatic aggravation after corticosteroid pulse therapy in definite sporadic Creutzfeldt-Jakob disease with the feature of Hashimoto's encephalopathy.
Jang JW; Park SY; Park YH; Kim JE; Kim S
BMC Neurol; 2014 Sep; 14():179. PubMed ID: 25196053
[TBL] [Abstract][Full Text] [Related]
13. Serum tau protein as a marker for the diagnosis of Creutzfeldt-Jakob disease.
Noguchi-Shinohara M; Hamaguchi T; Nozaki I; Sakai K; Yamada M
J Neurol; 2011 Aug; 258(8):1464-8. PubMed ID: 21360196
[TBL] [Abstract][Full Text] [Related]
14. Levels of plasma brain-derived tau and p-tau181 in Alzheimer's disease and rapidly progressive dementias.
Gonzalez-Ortiz F; Karikari TK; Bentivenga GM; Baiardi S; Mammana A; Turton M; Kac PR; Mastrangelo A; Harrison P; Capellari S; Zetterberg H; Blennow K; Parchi P
Alzheimers Dement; 2024 Jan; 20(1):745-751. PubMed ID: 37858957
[TBL] [Abstract][Full Text] [Related]
15. Total and Phosphorylated Cerebrospinal Fluid Tau in the Differential Diagnosis of Sporadic Creutzfeldt-Jakob Disease and Rapidly Progressive Alzheimer's Disease.
Hermann P; Haller P; Goebel S; Bunck T; Schmidt C; Wiltfang J; Zerr I
Viruses; 2022 Jan; 14(2):. PubMed ID: 35215868
[TBL] [Abstract][Full Text] [Related]
16. Atypical presentation of Creutzfeldt-Jakob disease: a rare but important cause of rapidly progressive dementia.
Taillefer MS; Tangarorang GL; Kuchel GA; Menkes DL
Conn Med; 2011 Sep; 75(8):473-8. PubMed ID: 21980678
[TBL] [Abstract][Full Text] [Related]
17. COVID-19-associated encephalitis or Creutzfeldt-Jakob disease: a case report.
Tayyebi G; Malakouti SK; Shariati B; Kamalzadeh L
Neurodegener Dis Manag; 2022 Feb; 12(1):29-34. PubMed ID: 34854312
[No Abstract] [Full Text] [Related]
18. Creutzfeldt-Jakob disease: a case report and differential diagnoses.
Kojima G; Tatsuno BK; Inaba M; Velligas S; Masaki K; Liow KK
Hawaii J Med Public Health; 2013 Apr; 72(4):136-9. PubMed ID: 23795314
[TBL] [Abstract][Full Text] [Related]
19. Abnormal proteins in the cerebrospinal fluid of patients with Creutzfeldt-Jakob disease.
Harrington MG; Merril CR; Asher DM; Gajdusek DC
N Engl J Med; 1986 Jul; 315(5):279-83. PubMed ID: 3523251
[TBL] [Abstract][Full Text] [Related]
20. Drug-induced Creutzfeldt-Jakob disease-like syndrome: early CSF analysis as useful tool for differential diagnosis.
Paolini Paoletti F; Di Gregorio M; Calabresi P; Parnetti L
BMJ Case Rep; 2018 Dec; 11(1):. PubMed ID: 30567187
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
